KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Assets Average (2018 - 2025)

Bionano Genomics' Assets Average history spans 7 years, with the latest figure at $77.5 million for Q3 2025.

  • For Q3 2025, Assets Average fell 28.45% year-over-year to $77.5 million; the TTM value through Sep 2025 reached $77.5 million, down 28.45%, while the annual FY2024 figure was $145.5 million, 44.23% down from the prior year.
  • Assets Average for Q3 2025 was $77.5 million at Bionano Genomics, roughly flat from $77.2 million in the prior quarter.
  • Across five years, Assets Average topped out at $370.8 million in Q2 2021 and bottomed at $77.2 million in Q2 2025.
  • The 5-year median for Assets Average is $226.6 million (2023), against an average of $232.4 million.
  • The largest annual shift saw Assets Average soared 1501.67% in 2021 before it plummeted 58.61% in 2024.
  • A 5-year view of Assets Average shows it stood at $368.4 million in 2021, then dropped by 14.33% to $315.6 million in 2022, then plummeted by 37.21% to $198.2 million in 2023, then crashed by 58.61% to $82.0 million in 2024, then fell by 5.46% to $77.5 million in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Assets Average are $77.5 million (Q3 2025), $77.2 million (Q2 2025), and $77.5 million (Q1 2025).